Additional file 4: Supplementary Fig. 4. Cellular heterogeneity in the myeloma of MM patients. (A) Heterogeneity score of the myeloma in NDMM and RRMM patients. (B) Single-cell atlas based on t-SNE showing heterogeneity of malignant subclonal ecological components in different MM patients. (C) Specific markers of malignant subclones in patients with NDMM and RRMM. Left: Expression pattern of malignant subclonal-specific marker genes in patients. Right: TFs that regulate malignant subclonal-specific markers. (D) Contribution of cell subsets with malignant subclone-specific markers in patients. Left: Expression patterns of malignant subclonal-specific marker genes in patients. The malignant subclonal marker genes illustrated are those that ar...
Plasma cell dyscrasias are a heterogeneous group of diseases characterized by the expansion of bone ...
Multiple myeloma (MM) has two clinical precursor stages of disease: monoclonal gammopathy of undeter...
To identify molecularly defined subgroups in multiple myeloma, gene expression profiling was perform...
Additional file 3: Supplementary Fig. 3. Exploring malignant origins from the perspective of clonal ...
Additional file 5: Supplementary Fig. 5. Expression patterns of immune cell subpopulations in MM. (A...
Additional file 9: Supplementary Table 4. Specific marker genes of malignant plasma cell subclones i...
Additional file 1: Supplementary Fig. 1. BM intercellular communication events in patients with NDMM...
Additional file 2: Supplementary Fig. 2. Nanopore sequencing combined with single-cell transcriptome...
Additional file 10: Supplementary Table 5. Specific marker genes of BM tumor microenvironment cells ...
Additional file 6: Supplementary Table 1. Demographic, clinical, molecular, and diagnostic informati...
Additional file 11: Supplementary Table 6. Characterization of specific marker genes for type I and ...
Additional file 8: Supplementary Table 3. Specific marker genes of control donor BM cells. BM, bone ...
Additional file 7: Supplementary Table 2. The known marker genes used for annotating cell clusters
Additional file 12: Supplementary Table 7. Relative abundance estimation and typing of type I and IX...
Additional file 12: Figure S5. Characterization of myeloid cells in the KUL3 cohort. A. UMAP plot of...
Plasma cell dyscrasias are a heterogeneous group of diseases characterized by the expansion of bone ...
Multiple myeloma (MM) has two clinical precursor stages of disease: monoclonal gammopathy of undeter...
To identify molecularly defined subgroups in multiple myeloma, gene expression profiling was perform...
Additional file 3: Supplementary Fig. 3. Exploring malignant origins from the perspective of clonal ...
Additional file 5: Supplementary Fig. 5. Expression patterns of immune cell subpopulations in MM. (A...
Additional file 9: Supplementary Table 4. Specific marker genes of malignant plasma cell subclones i...
Additional file 1: Supplementary Fig. 1. BM intercellular communication events in patients with NDMM...
Additional file 2: Supplementary Fig. 2. Nanopore sequencing combined with single-cell transcriptome...
Additional file 10: Supplementary Table 5. Specific marker genes of BM tumor microenvironment cells ...
Additional file 6: Supplementary Table 1. Demographic, clinical, molecular, and diagnostic informati...
Additional file 11: Supplementary Table 6. Characterization of specific marker genes for type I and ...
Additional file 8: Supplementary Table 3. Specific marker genes of control donor BM cells. BM, bone ...
Additional file 7: Supplementary Table 2. The known marker genes used for annotating cell clusters
Additional file 12: Supplementary Table 7. Relative abundance estimation and typing of type I and IX...
Additional file 12: Figure S5. Characterization of myeloid cells in the KUL3 cohort. A. UMAP plot of...
Plasma cell dyscrasias are a heterogeneous group of diseases characterized by the expansion of bone ...
Multiple myeloma (MM) has two clinical precursor stages of disease: monoclonal gammopathy of undeter...
To identify molecularly defined subgroups in multiple myeloma, gene expression profiling was perform...